Nicklin SA - Search Results

1

Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor.

Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, Graham D, Nicklin SA. Flores-Munoz M, et al. Among authors: nicklin sa. Hypertension. 2012 Feb;59(2):300-7. doi: 10.1161/HYPERTENSIONAHA.111.177485. Epub 2011 Dec 19. Hypertension. 2012. PMID: 22184331

2

Identification of peptides that target the endothelial cell-specific LOX-1 receptor.

White SJ, Nicklin SA, Sawamura T, Baker AH. White SJ, et al. Among authors: nicklin sa. Hypertension. 2001 Feb;37(2 Pt 2):449-55. doi: 10.1161/01.hyp.37.2.449. Hypertension. 2001. PMID: 11230317

3

Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium.

Nicklin SA, Reynolds PN, Brosnan MJ, White SJ, Curiel DT, Dominiczak AF, Baker AH. Nicklin SA, et al. Hypertension. 2001 Jul;38(1):65-70. doi: 10.1161/01.hyp.38.1.65. Hypertension. 2001. PMID: 11463761

4

Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.

Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, Baker AH. Nicklin SA, et al. Mol Ther. 2001 Dec;4(6):534-42. doi: 10.1006/mthe.2001.0489. Mol Ther. 2001. PMID: 11735337 Free article.

5

Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension.

Fennell JP, Brosnan MJ, Frater AJ, Hamilton CA, Alexander MY, Nicklin SA, Heistad DD, Baker AH, Dominiczak AF. Fennell JP, et al. Among authors: nicklin sa. Gene Ther. 2002 Jan;9(2):110-7. doi: 10.1038/sj.gt.3301633. Gene Ther. 2002. PMID: 11857069

6

Use of phage display to identify novel peptides for targeted gene therapy.

Work LM, Nicklin SA, White SJ, Baker AH. Work LM, et al. Among authors: nicklin sa. Methods Enzymol. 2002;346:157-76. doi: 10.1016/s0076-6879(02)46055-7. Methods Enzymol. 2002. PMID: 11883067

7

Targeting gene therapy vectors to the vascular endothelium.

Work LM, Nicklin SA, Baker AH. Work LM, et al. Among authors: nicklin sa. Curr Atheroscler Rep. 2003 May;5(3):163-70. doi: 10.1007/s11883-003-0019-9. Curr Atheroscler Rep. 2003. PMID: 12667427 Review.

8

Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy.

Dishart KL, Denby L, George SJ, Nicklin SA, Yendluri S, Tuerk MJ, Kelley MP, Donahue BA, Newby AC, Harding T, Baker AH. Dishart KL, et al. Among authors: nicklin sa. J Mol Cell Cardiol. 2003 Jul;35(7):739-48. doi: 10.1016/s0022-2828(03)00136-6. J Mol Cell Cardiol. 2003. PMID: 12818564

9

Development of efficient viral vectors selective for vascular smooth muscle cells.

Work LM, Nicklin SA, Brain NJ, Dishart KL, Von Seggern DJ, Hallek M, Büning H, Baker AH. Work LM, et al. Among authors: nicklin sa. Mol Ther. 2004 Feb;9(2):198-208. doi: 10.1016/j.ymthe.2003.11.006. Mol Ther. 2004. PMID: 14759804 Free article.

10

Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.

Work LM, Ritchie N, Nicklin SA, Reynolds PN, Baker AH. Work LM, et al. Among authors: nicklin sa. Gene Ther. 2004 Aug;11(16):1296-300. doi: 10.1038/sj.gt.3302292. Gene Ther. 2004. PMID: 15292916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters